Section Arrow
NTRA.NASDAQ
- Natera
Quotes are at least 15-min delayed:2026/01/09 21:23 EST
Regular Hours
Last
 234.31
-5.25 (-2.19%)
Day High 
241.9 
Prev. Close
239.56 
1-M High
256.36 
Volume 
1.02M 
Bid
234.51
Ask
254
Day Low
232.36 
Open
241.84 
1-M Low
221.84 
Market Cap 
33.41B 
Currency 美元 
P/E -- 
%Yield -- 
10-SMA 236.86 
20-SMA 233.69 
50-SMA 223.69 
52-W High 256.36 
52-W Low 125.38 
Exchange NASDAQ 
Valuation Estimation
EPS (Current/Estimated)
-2.29/0.62
Enterprise Value
33.50B
Balance Sheet
Book Value Per Share
8.98
Cash Flow
Cash Flow Yield
0.01
Income Statement
Total Revenue
1.70B
Operating Revenue Per Share
6.68
Industry Comparison
Code Name   Last Change Change (%) P/E P/E Range
NEOGNeogen Corp9.62-0.09-0.93%879PE
SHCSotera Health Company19.2+0.39+2.07%94.05PE
DHRDanaher Corp238.37+3.37+1.43%48.35PE
OPKOPKO Health1.36-0.01-0.73%-- 
GHGuardant Health110.17+1.43+1.32%-- 
Industry overview quotes are at least 15 minutes delayed
Business Description
Natera Inc is a diagnostic and research company with proprietary molecular and bioinformatics technology. The company's key product offerings include its Panorama Non-Invasive Prenatal Test (NIPT) which screens for chromosomal abnormalities of a fetus as well as in twin pregnancies, typically with a blood draw from the mother, Horizon Carrier Screening (HCS) to determine carrier status for a large number of severe genetic diseases that could be passed on to the carrier's children, Signatera molecular residual disease (MRD) test, which detects circulating tumor DNA in patients previously diagnosed with cancer to assess molecular residual disease and monitor for recurrence; and Prospera, to assess organ transplant rejection.
Information provided by: etnet
Terms and Conditions
Bank of China (Hong Kong) Limited
Disclaimer:
This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources and Bank of China (Hong Kong) Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information.